期刊文献+

多种肿瘤标志物在肝脏疾病中的对比研究 被引量:2

Comparative Study on Diagnostic Value of Several Serum Tumor Markers in Liver Diseases
下载PDF
导出
摘要 目的:比较几种临床常用肿瘤标志物(TM)对肝脏良、恶性疾病的鉴别诊断能力。方法:回顾性分析6个TM(AFP、CEA、CA50、CA125、CA15-3和CA19-9)在421例肝脏良、恶性疾病中的浓度变化,绘制ROC曲线并进行Mann-WhitneyU检验和二元Logistic回归分析。结果:肝囊肿病人第90百分位数的6个TM全部位于正常参考值范围内。与之相比,慢性肝炎患者6个TM均出现明显升高(P=0.000~0.032)。肝硬化较慢性肝炎病人CA125、CEA和CA19-9进一步升高(P<0.05)。原发性肝癌较肝硬化只有AFP升高显著,ROC曲线下面积(0.733)最大,二元Logistic回归分析表明AFP是原发性肝癌的独立危险因子。转移性肝癌CEA较其他各疾病组明显升高(P<0.001)。结论:AFP和CEA是鉴别原发性肝癌与其他肝脏疾病的主要TM;CA50、CA153、CA125和CA19-9在肝硬化和原发性肝癌患者中的浓度无显著差异,对具有肝硬化病史的患者进行TM分析时需慎重。 Objective To compare the diagnostic capability of six commonly - used serum tumor markers (TM) in liver disease. Method Serum contents of six TMs, AFP, CEA, CA50, CA125, CA15 -3 and CA19 -9, were statistically analyzed with ROC curve, Mann- Whitney U- test and binary logistic regression in 421 patients with varidus kinds of benign or malignant liver diseases. Results Ninety percent of patients with hepatic cyst had all 6 TMs within normal reference range, while all the patients with chronic hepatitis had the 6 TMs increased significantly (P =0.000 ~0. 032). Further increases in serum in CA125, CEA and CA19 -9 contents were seen in patients with cirrhosis ( P 〈 0.05 ). AFP was the only TM with serum contents significantly higher in patients with primary liver cancer than those in patients with cirrhosis, and had the largest area under ROC curve (0. 733 ). Logistic regression analysis revealed that AFP was an independent risk factor for primary liver cancer. CEA contents were very significantly higher in patients with metastatic liver cancer than in patients other liver with diseases ( P 〈 0. 001 ). Conclusion AFP and CEA were the two most useful markers for the diagnosis of hepatic malignancy. CA50, CA153,CA125 and CA19 -9 contents were increased to a similar degree in cirrhosis and primary liver cancer, so their usfulness for differential dragnosis was limited.
出处 《放射免疫学杂志》 CAS 2006年第2期146-148,共3页 Journal of Radioimmanology
关键词 肿瘤标志物 原发性肝癌 肝硬化 慢性肝炎 tumor markers, primary liver cancer, chronic hepatitis, cirrhosis
  • 相关文献

参考文献10

  • 1Ryder SD.Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.Gut.2003,52(suppl Ⅲ):iii1.
  • 2劳明,朱波,黄玲莎,黄文成,李佩章,赵惠柳.三种肿瘤标志物联合检测对原发性肝癌的诊断价值[J].中华消化杂志,2005,25(2):109-110. 被引量:38
  • 3马京香,宫奇林,林梅青,袭燕,王民玉,陈珠峰,裴忠亚,马万山.多项肿瘤标志物联合检测早期诊断原发性肝癌的研究[J].中华外科杂志,2000,38(1):14-16. 被引量:27
  • 4施先艳,周燕,夏琳,肖建群,邓长生.若干肿瘤标志物对原发性肝癌诊断的临床评价[J].中华肿瘤杂志,1998,20(6):437-439. 被引量:38
  • 5Zhou XH,Obuchowshi NA,McClish DK.诊断医学统计学.宇传华译.第1版.北京:人民卫生出版社.2005,3.
  • 6武建国.血清肿瘤标志物检测中值得注意的问题[J].中华医学检验杂志,1997,20(1):7-8. 被引量:27
  • 7Rai AJ,Zhang Z,Rosenzweig J,et al.Proteomic approaches to tumor marker discovery:identification of biomarkers for ovarian cancer.Arch Pathol Lab Med.2002,126:1518.
  • 8Rasouli M,Okhovatian A,Enderami A.Serum proteins profile as an indicator of malignancy:multivariate logistic regression and ROC analyses.Clin Chem Lab Med.2005,43:913.
  • 9Schutter EM,Davelaar EM,Van Kamp GJ,et al.The differential diagnostic potential of a panel of tumor markers (CA125,CA15-3,and CA72-4 antigens) in patients with a pelvic mass.Am J Obstet Gynecol.2002,187:385.
  • 10Carpelan-Holmstrom M,Louhimo J,Stenman UH,et al.Estimating the probability of cancer with several tumor markers in patients with colorectal disease.Oncology.2004,66:296.

二级参考文献10

共引文献117

同被引文献38

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部